The action of heparin in the prevention of prothrombin conversion.
作者信息
DOUGLAS A S
出版信息
J Clin Invest. 1956 May;35(5):533-6. doi: 10.1172/JCI103306.
Abstract
摘要
相似文献
1
The action of heparin in the prevention of prothrombin conversion.
J Clin Invest. 1956 May;35(5):533-6. doi: 10.1172/JCI103306.
2
[Effect of heparin on prothrombinic activity, on circulatory anticoagulants (antithromboplastin, plasma and serum antithrombin, antifibrinogen, on utilization of prothrombin, on conversion and acceleration factors in prothrombin conversion, on proteinemia, and on protein fraction].
Arch Sci Med (Torino). 1952 Jan;93(1):9-16.
3
[Activation by heparin-Sepharose of prothrombin conversion to prethrombin 1].
Biokhimiia. 1981 May;46(5):904-10.
4
ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy.
Scand J Clin Lab Invest. 2016;76(3):202-7. doi: 10.3109/00365513.2015.1137347. Epub 2016 Feb 22.
5
The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
N Engl J Med. 1952 Jan 3;246(1):15-7. doi: 10.1056/NEJM195201032460104.
6
[Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
Policlinico Chir. 1956 May-Jun;63(3):141-59.
7
INCREASED SENSITIVITY TO HEPARIN FOLLOWING ACUTE MYOCARDIAL INFARCTION.
Can Med Assoc J. 1965 Jan 2;92(1):13-5.
8
[Residual prothrombin after intravenous injection of 50 mg. of heparin in diabetic subjects].
Boll Soc Ital Biol Sper. 1951 Jun;27(6):1015-6.
9
[Plasma prothrombin-proconvertin content following therapeutic doses of heparin].
Ugeskr Laeger. 1956 Jan 12;118(2):38-9.
10
Effects of S-hexyl-L-cysteine derivatives on prothrombin activation and clotting time determined in the presence of heparin.
Adv Med Sci. 2009;54(1):47-50. doi: 10.2478/v10039-009-0013-8.
引用本文的文献
1
The effect of heparin on the early stages of blood coagulation.
J Clin Pathol. 1960 Mar;13(2):93-8. doi: 10.1136/jcp.13.2.93.
2
Effect of Polybrene on blood coagulation of dogs.
Ann Surg. 1962 Dec;156(6):875-81. doi: 10.1097/00000658-196212000-00003.
3
Hematological and pathological studies of the effects of four-hour perfusion level heparinization on dogs.
Ann Surg. 1962 Mar;155(3):392-7. doi: 10.1097/00000658-196203000-00007.
4
Heparin-like anticoagulant occurring in association with chronic nephritis.
Br Med J. 1959 Jul 11;2(5140):38-9. doi: 10.1136/bmj.2.5140.38.
5
Vasculas complications in nephrotic syndrome: relationship to steroid therapy and accelerated thromboplastin generation.
Br Med J. 1970 Oct 31;4(5730):273-6. doi: 10.1136/bmj.4.5730.273.
6
Effect of dextran sulphates on thrombin activity.
J Clin Pathol. 1979 May;32(5):439-44. doi: 10.1136/jcp.32.5.439.
本文引用的文献
1
Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships.
Blood. 1950 Apr;5(4):303-12.
2
Anticoagulants and anticoagulant therapy; a review.
Glasgow Med J. 1952 Jun;33(6):225-54.
3
The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.
J Clin Invest. 1951 Mar;30(3):252-62. doi: 10.1172/JCI102439.
4
A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.
J Clin Invest. 1955 Apr;34(4):602-13. doi: 10.1172/JCI103109.
5
Assessment of clotting efficiency.
Br Med Bull. 1955;11(1):5-10. doi: 10.1093/oxfordjournals.bmb.a069445.
6
7
Heparin and thromboplastin.
J Lab Clin Med. 1954 Sep;44(3):378-86.
8
A possible fourth plasma thromboplastin component.
J Clin Invest. 1954 Aug;33(8):1095-102. doi: 10.1172/JCI102982.
9
The action of thromboplastic substances.
J Physiol. 1953 Dec 29;122(3):554-69. doi: 10.1113/jphysiol.1953.sp005020.
10
The consumption of some components involved in physiological blood coagulation.
Glasgow Med J. 1953 Aug;34(8):329-42.
Zotero 插件